Roche Holding
CHF 349.00Change from previous close: −0.03%Absolute change: −CHF 0.10
Valuation
Data as of October 1, 2026
Valuation multiples
- Market cap
- CHF 278.07B
- Enterprise value
- CHF 305.67B
- P/E (trailing 12 months)
- 22.8
- Forward P/E
- 15.9
- PEG
- 1.60
- Price/book
- 8.51
- Price/sales
- 4.42
- EV/EBITDA
- 12.8
- EV/revenue
- 4.86
Profitability and growth
- Gross margin
- 74.2%
- Operating margin
- 36.2%
- Net margin
- 19.6%
- ROE
- 38.1%
- ROA
- 13.5%
- Revenue growth (year over year)
- -1.2%
- Earnings growth (year over year)
- -7.7%
Financial health
- Total cash
- CHF 9.73B
- Total debt
- CHF 33.31B
- Debt/equity
- 0.91
- Current ratio
- 1.23
- Quick ratio
- 0.80
Dividends
- Annual dividend per share
- CHF 9.80
- Dividend yield
- 2.8%
- Payout ratio
- 63.9%
- Ex-dividend date
- March 12, 2026
Analysts and estimates
- Average price target
- CHF 375.34
- Median price target
- CHF 381.00
- High price target
- CHF 434.50
- Low price target
- CHF 230.00
- Analysts with a price target
- 19
- Consensus
- Buy
- Forward EPS
- CHF 21.91
- EPS estimate, current year
- CHF 20.45
Shares and trading
- Beta
- 0.35
- Average volume
- 897.57K
- Shares outstanding
- 690.07M
- Float
- 654.09M
- Institutional ownership
- 44.0%
- Insider ownership
- 0.0%